Overview

Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease

Status:
Active, not recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The aim of the project is to study pathogenetic mechanisms in severe asthma and compare those mechanisms in chronic obstructive pulmonary disease (COPD) in order to test the hypothesis that severe asthma and COPD develop into similar chronic degenerative changes.
Phase:
N/A
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
Imperial College London
Jagiellonian University
Leiden University Medical Center
Pulmonary Research Institute Grosshansdorf
Università degli Studi di Ferrara
Université Montpellier
University Ghent
University Hospital of Crete
University of Athens
University of Southampton
Treatments:
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate